News Focus
News Focus
icon url

SidVicious

01/19/23 1:11 PM

#116542 RE: Siriam #116541

Ok. But just keep this between us okay? I could get into trouble sharing this insider information.

I am told by my in the know source that Koos is looking to sell the IP to a big pharma for around the same price Kite got from Gilead.

The sticking point is that the big pharma wants P2 data first.